Recursion Projects 2028 Runway, Holds 2026 Expenses Below $390M
Recursion Pharmaceuticals projects its operational runway into early 2028 while committing to keep 2026 cash operating expenses under $390 million, driven by...

Recursion Pharmaceuticals projects its operational runway into early 2028 while committing to keep 2026 cash operating expenses under $390 million, driven by...

Alphabet's Google Cloud is outpacing Amazon and Microsoft in growth, with a massive backlog signaling future dominance, making its stock a compelling...

Analysts identify Nvidia, Nebius, and IonQ as key players with substantial growth prospects in the burgeoning artificial intelligence sector.

IBM is expanding its footprint in artificial intelligence and quantum computing with the launch of two new innovation hubs in Illinois and...

Companies are upgrading their data moats with AI, shifting focus from sheer data volume to context, metadata, and domain intelligence for actionable...

Maverick Payments' Justin Downey argues that accumulating data is no longer a competitive advantage. Intentional data utilization is key for business growth...

GridBeyond leverages AI and energy storage to optimize global grids, delaying costly infrastructure upgrades. The firm recently secured investment from Samsung Ventures.

Credit unions risk falling behind as consumers increasingly expect AI-driven interactions. Early adoption of conversational AI is now a necessity, not an...

UnitedHealth Group is investing $1.5 billion in AI for 2026, aiming for a conservative 2-to-1 return by streamlining claims, authorizations, and member...